Activation of PI3K signaling repressed the induction of MHCI and MHCII in oral carcinoma cells [338], and PI3K inhibition improved MHCI presentation and rendered tumor cells sensitive to recognition by CD8+ T-cells [339]. The gene discussed is CD8A; the disease is neoplasm.